Hacker News new | ask | show | jobs
by incrudible 1239 days ago
Again, it was just an assumption that vaccines would be "safe enough", despite no mRNA vaccine having ever been rolled out at scale. The "profit" issue disappeared with COVID vaccines. You now have the FDA proposing annual COVID boosters and combined mRNA-COVID/Influenza shots for everyone, whereas European countries are age-restricting COVID boosters. If that doesn't smell like regulatory capture to you, you might suffer from COVID-induced anosmia.
2 comments
SamoyedFurFluff 1239 days ago
You’re saying a lot to dodge the fact you made a claim using a source that doesn’t actually back your claim. You claimed this article showed mrna vaccines weren’t widely distributed because they weren’t considered safe. But this article isn’t saying that and all, and you’re misrepresenting it.
link
incrudible 1239 days ago
I never made this claim. I said the technology had safety issues, which the article supports. In the following paragraph, I claim that mRNA vaccines were assumed to be safe enough due to the lower dosage. Again, the article supports this.
link
Timon3 1239 days ago
> Again, it was just an assumption that vaccines would be "safe enough", despite no mRNA vaccine having ever been rolled out at scale.

Why is this a criterium we should pay attention to? If you never roll anything out, you'll never have data about a roll out. So instead we do studies and statistical analyses. Are you aware of any studies that "normal"/previous vaccines had to go through, which mRNA COVID vaccines did not? If so, could you please share them?

link
incrudible 1239 days ago
I'm not aware of any approved vaccine where the observation period in the RCT was a mere four months and the control group was vaccinated thereafter. If there is another such vaccine, I would be hesitant to take that one as well.

There's no controlled experiment to suggest that mRNA vaccines provide a survival advantage to a healthy individual. The brief RCTs certainly don't support it. The increased cardiac risk, small as it may be, may well put the vaccine into negative benefit territory for some, but we'll probably never know for sure, because none of our data is robust enough to draw such conclusions.

link